SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-13-081325
Filing Date
2013-11-05
Accepted
2013-11-05 20:49:09
Documents
2
Period of Report
2013-11-05

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 16044
2 EX-24.1 ex-24d1.htm EX-24.1 9880
  Complete submission text file 0001104659-13-081325.txt   27233
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 2 MERCER ROAD NATICK MA 01760
Business Address
Shacham Sharon (Reporting) CIK: 0001588438 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36167 | Film No.: 131194398